With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Do gender perceptions affect the way female physicians are treated in cardiology? Drs Melissa Walton-Shirley, Judith Hochman, Suzanne Oparil, and Lynne Warner Stevenson tackle this important question.
Studies suggest public smoking bans reduce the incidence of acute MI. So why is America not smoke-free? Dr Melissa Walton-Shirley discusses this important issue with the AHA's Nancy Brown and Dr Clyde Yancy.
Distinguished by a lifelong commitment to rigorous investigation, Dr Carl Pepine shares his life path and gives insight on tomorrow's cardiology leaders and why it may be increasingly difficult for medicine to keep attracting the best and brightest.
Join Drs Harrington and Blumenthal as they shine a light on real and perceived conflicts between researchers and industry in a discussion moderated by heartwire's Shelley Wood.
Watch Drs Bob Harrington, Sanjay Kaul, and Gregg Stone as they debate the future of ticagrelor in a discussion moderated by heartwire's Lisa Nainggolan.
AHA president Dr Clyde Yancy and CEO Nancy Brown share insights from the recent sessions and discuss ongoing initiatives with heartwire's Shelley Wood.
Raised in a blue-collar neighborhood of Somerville, MA, Dr Bob Harrington was blessed to have a strong family and the Jesuits on his side as he traveled from "Yankee" Boston to Duke University. Join him as he tells his story to Dr Rob Califf.
How do regulatory pathways differ in the US and UK? Drs Harrington, Bhatt, and Cleland share their experiences and offer insight on how to support innovative research.
With the ISIS-1 trial, Dr Peter Sleight and his team at Oxford changed the approach to cardiovascular research. Join Dr Robert Califf as he talks to Dr Sleight about his journey from London to San Francisco to Oxford and finally to Italy, where he discovered the music of the heart.
Drs Bonhoeffer and Kovac discuss size, sterility, location, presence of multidisciplinary teams, and imaging techniques - issues to consider in creating an ideal lab that can also adapt to future technologies and developments.
Exactly three years after the DES firestorm ignited the World Congress of Cardiology in Barcelona, heartwire's Shelley Wood sifts through the ashes with Drs Tony Gershlick, Christian Spaulding, and Renu Virmani in a discussion on DES safety and what we've learned since September 2006.
Dr Robert Califf sits down with Drs Alfred Bove, Jack Lewin, and Clyde Yancy and AHA CEO Nancy Brown to talk about the ACC and the AHA and their role in the debate on healthcare reform.
Join Drs Valentin Fuster, William E Boden, and George D Dangas as they discuss the results, plus the evolution of therapy over the last forty years, the mechanisms of coronary artery disease progression in diabetic patients, and what is perhaps one of the most fundamental problems in the field: that patients today are still not treated to target with best medical therapy.
Join Dr Robert Califf for a probing and personal interview with Dr Steve Nissen, about his activist days at the University of Michigan and the development of IVUS, to how he ended up at the Cleveland Clinic and what he thinks about the future of medicine in America.
With the global trend leaning toward increased use of transradial access, our international panel reports on standard practice at their respective institutions and the key issues that influence it such as bleeding, access-site complications, stroke risk, patient mobility, and operator experience. Join Drs Kandzari (US), Feres (Brazil), Le May (Canada), and Steg (France) for this thoughtful and practical discussion.
Join Drs Valentin Fuster, Anne Curtis, Timothy Gardner, Barry Greenberg, Cindy Grines, Bob Harrington, Sanjay Kaul, Harlan Krumholz, and Salim Yusuf as they unravel the STICH trial and debate the lessons learned from PROTECT-AF in Part 1 of the Cardiology Show. In Part 2 of the program, the JUPITER trial is back on the table and our experts give their opinion on the polypill following the results of the TIPS study.
Drs Gregg Stone and William Weintraub discuss the misconceptions some patients have about the benefits and purpose of elective PCI and what can be done to rectify them in a candid discussion moderated by heartwire's Shelley Wood.
As theheart.org enters its 10th year join editor-in-chief, Dr Eric Topol, and his guests for a second look at the top news from the past decade. Throughout the coming months, we'll revisit the most important story from each of the last 10 years and ask: How has practice been affected? With time and perspective, what has changed and what have we learned?
Join Drs Raymond Gibbons, Antonio Colombo, William Boden, Ph Gabriel Steg, and Valentin Fuster for another look at the COURAGE trial, as they discuss the latest data and talk about where things stand now on the larger controversy.
Dr Melissa Walton-Shirley talks to Drs Ph Gabriel Steg and Raymond Gibbons about the differences in STEMI care on both sides of the Atlantic and what US cardiologists can learn from their colleagues in Europe.
Despite data suggesting that only the culprit lesion should be treated in ACS patients, it's often hard to ignore significant blockages seen on angiography. Dr. Feres presents a case to Drs. Bhatt and King who discuss strategies to quantify risk and manage ACS patients with multivessel disease.
COMPARE, ENDEAVOR IV, SIRTAX-LATE, SPIRIT IV -- given the abundance of data comparing the various DES are there any patterns emerging? Dr. King leads a panel discussion with Drs. Cohen and Williams.
Join Drs. Garratt and Waksman as they discuss the recent information overload from drug-eluting stent trials and to what extent these data impact their clinical practice.
Drs Moses, Singh and DeGregorio present a series of challenging case studies of patients with complex cardiovascular lesions and discuss how new and evolving technologies will impact the management of these patients.
Recorded at the Dallas-Leipzig meeting 2009. Watch presentations by Drs. Dewey, Kappetein, Schuler, and Walther bookended by commentary from course directors, Drs. Mack and Mohr.
The percutaneous pulmonary valve (PPV) was the first transcatheter valve developed. Dr. Ziyad Hijazi discusses this work with PPV inventor, Dr. Philipp Bonhoeffer, including the European and US experience so far in patients with prior right ventricular outflow tract surgery.
How do drug-eluting stents compare? Our panel of experts, Drs. Stone, Kereiakes, Serruys, and Windecker discuss the late-breaking trials at TCT 2009 of DES vs DES.